Tatva Chintan Pharma Chem Limited (TATVA.NS)
Makes specialty chemicals for pharmaceuticals, automotive, and industrial applications
1,744.40+0.02%Basic Materials
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+56.4%
The outlook
Tatva Chintan is trading near its 52-week highs, well above its moving averages, but analyst sentiment is mixed with a "Hold" consensus and an average price target about 17% below current levels. The trailing P/E of 79.3 reflects a richly valued stock despite the technical strength. Current data shows the price in an elevated position within its recent range.
What’s behind the score
Analyst consensusHold — 2.8 avg of 4 analysts
Price trendAbove its 50- & 200-day averages
52-week range89% of the way from its 52-week low to high
Price targetAvg target -17% vs current price
Analyst price target
~12-month · 4 analysts1,442.50average target-17.3% vs now
Now 1,744.40
Low 835.00High 1,955.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$40.81B
52-wk high
1,835.00
52-wk low
976.40
50-day avg
1,288.93
200-day avg
1,295.41
Trailing P/E
79.3